subsidiaries increased Baht 79.27 million from profit sharing from investment in BBF. 4. Property, plant and equipment increased Baht 88.58 million, mostly from the adoption of new financial reporting standards
% VS NTA financial statements for the period 1. VNG and subsidiaries trade among related companies. 25 Feb. 2020 43,000,000.00 0.701% as at 31 Dec.2019 2. Vanachai Panel Industries Co., Ltd. uses the
) Transaction Size% VS NTA financial statements for the period 1. VNG and subsidiaries trade among related companies. 25 Feb. 2020 43,000,000.00 0.701% as at 31 Dec. 2019 2. Vanachai Panel Industries Co., Ltd
Release Date Value (Baht) Transaction Size% VS NTA financial statements for the period 1. VNG and subsidiaries trade among related companies. 25 Feb. 2020 43,000,000.00 0.701% as at 31 Dec. 2019 2. Vanachai
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
Company Limited and its subsidiaries (“the Company”) reported consolidated revenues of Baht 277.3 million, decreased by 42.3% compared to the same quarter last year, majorly due to the Covid-19 pandemic
financial statements, including the consolidated financial statements of the Company and its subsidiaries for the third quarter and nine month period ended 30th September 2019. The Company reported
business strategy and enhance marketing strategy for both domestic and international market to achieve more targeted customers. For the three-month period 2019, Subsidiaries can reduce the cost of sales, by
income tax because high proportion of the increase in profit before income tax expense was derived from subsidiaries’ promoted operations, which were exempt from corporate income tax. Profit for the year
In 1Q2022, income tax expense was THB 3.75 million, decreased by -0.03% YoY because high pro- portion of the decrease in profit before income tax expense was the profit from subsidiaries’ promoted